Free Trial
NASDAQ:PAHC

Phibro Animal Health Q4 2025 Earnings Report

Phibro Animal Health logo
$32.46 +0.91 (+2.88%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$32.44 -0.02 (-0.05%)
As of 08/22/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Phibro Animal Health EPS Results

Actual EPS
N/A
Consensus EPS
$0.52
Beat/Miss
N/A
One Year Ago EPS
N/A

Phibro Animal Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$362.24 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Phibro Animal Health Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
Thursday, August 28, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Phibro Animal Health Earnings Headlines

Q4 EPS Forecast for Phibro Animal Health Reduced by Analyst
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.tc pixel
PAHC Phibro Animal Health Corporation - Seeking Alpha
See More Phibro Animal Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Phibro Animal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Phibro Animal Health and other key companies, straight to your email.

About Phibro Animal Health

Phibro Animal Health (NASDAQ:PAHC) operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

View Phibro Animal Health Profile

More Earnings Resources from MarketBeat